Gideon M Hirschfield (G M Hirschfield, Anand Ghanekar, Gideon Hirschfield)

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 38

Top Topics

Ulcerative Colitis

Immune Response

Top Venues

Alimentary pharmacology & therapeutics

Hepatology communications

Hepatology (Baltimore, Md.)

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

This page only lists publications with an associated author ORCID identifier.

Publications

Gideon M Hirschfield, Katherine Arndtz, Amanda Kirkham, Yung-Yi Chen, Richard Fox, Anna Rowe, Jessica Douglas-Pugh, Douglas Thorburn, Eleanor Barnes, Guruprasad P Aithal, Diana Hull, Khushpreet Bhandal, Kathryn Olsen, Paul Woodward, Siân Lax, Philip Noel Newsome, David J Smith, Antero Kallio, David H Adams, Victoria Homer, Christopher J Weston
Vascular adhesion protein-1 blockade in primary sclerosing cholangitis: Open-label, multicenter, single-arm, phase II trial. Hepatology communications 8 (5) (2024)
Owen Jones, Marco P A W Claasen, Tommy Ivanics, Woo Jin Choi, Felipe Gavaria, Luckshi Rajendran, Gideon M Hirschfield, Gideon M Hirschfield, Chaya Shwaartz, Trevor W Reichman, Blayne Amir Sayed, Markus Selzner, Mamatha Bhat, Cynthia Tsien, Elmar Jaeckel, Les Lilly, Ian D McGilvray, Mark Steven Cattral, Gonzalo Sapisochin, Gonzalo Sapisochin
Pursuing living donor liver transplantation improves outcomes of patients with autoimmune liver diseases: An intention-to-treat analysis. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 30 (8) (2024)
Palak J Trivedi, Katherine Arndtz, Nadir Abbas, Alison Telford, Liam Young, Rajarshi Banerjee, Peter Eddowes, Kartik S Jhaveri, Gideon M Hirschfield
Quantitative MRCP and metrics of bile duct disease over time in patients with primary sclerosing cholangitis: A prospective study. Alimentary pharmacology & therapeutics 59 (11) (2024)
David E J Jones, Ulrich H W Beuers, Alan Bonder, Marco Carbone, Emma L Culver, Jessica Katharine Dyson, Robert G Gish, Bettina E Hansen, Gideon M Hirschfield, Rebecca Jones, Kris Kowdley, Andreas E Kremer, Keith D Lindor, Marlyn J Mayo, George Mells, James Neuberger, Martin Prince, Mark G Swain, Atsushi Tanaka, Douglas Thorburn, Michael Trauner, Palak J Trivedi, Martin Weltman, Andrew D Yeoman, Cynthia Levy
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here? Hepatology (Baltimore, Md.) (2024)
Palak J Trivedi, Katherine Arndtz, Nadir Abbas, Alison Telford, Liam Young, Rajarshi Banerjee, Peter Eddowes, Kartik S Jhaveri, Gideon M Hirschfield
Quantitative MRCP and metrics of bile duct disease over time in patients with primary sclerosing cholangitis: A prospective study. Alimentary pharmacology & therapeutics 59 (11) (2024)
Owen Jones, Marco P A W Claasen, Tommy Ivanics, Woo Jin Choi, Felipe Gavaria, Luckshi Rajendran, Gideon M Hirschfield, Gideon M Hirschfield, Chaya Shwaartz, Trevor W Reichman, Blayne Amir Sayed, Markus Selzner, Mamatha Bhat, Cynthia Tsien, Elmar Jaeckel, Les Lilly, Ian D McGilvray, Mark Steven Cattral, Gonzalo Sapisochin, Gonzalo Sapisochin
Pursuing living donor liver transplantation improves outcomes of patients with autoimmune liver diseases: An intention-to-treat analysis. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 30 (8) (2024)
Nasir Hussain, James Ferguson, Gideon M Hirschfield, Palak J Trivedi
Primary sclerosing cholangitis and the risks of posttransplant lymphoproliferative disorder. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 30 (6) (2024)
Palak J Trivedi, Katherine Arndtz, Nadir Abbas, Alison Telford, Liam Young, Rajarshi Banerjee, Peter Eddowes, Kartik S Jhaveri, Gideon M Hirschfield
Quantitative MRCP and metrics of bile duct disease over time in patients with primary sclerosing cholangitis: A prospective study. Alimentary pharmacology & therapeutics (2024)
Gideon M Hirschfield, Katherine Arndtz, Amanda Kirkham, Yung-Yi Chen, Richard Fox, Anna Rowe, Jessica Douglas-Pugh, Douglas Thorburn, Eleanor Barnes, Guruprasad P Aithal, Diana Hull, Khushpreet Bhandal, Kathryn Olsen, Paul Woodward, Siân Lax, Philip Noel Newsome, David J Smith, Antero Kallio, David H Adams, Victoria Homer, Christopher J Weston
Vascular adhesion protein-1 blockade in primary sclerosing cholangitis: Open-label, multicenter, single-arm, phase II trial. Hepatology communications 8 (5) (2024)
Nasir Hussain, James Ferguson, Gideon M Hirschfield, Palak J Trivedi
Primary sclerosing cholangitis and the risks of posttransplant lymphoproliferative disorder. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2024)
Owen Jones, Marco P A W Claasen, Tommy Ivanics, Woo Jin Choi, Felipe Gavaria, Luckshi Rajendran, Gideon M Hirschfield, Gideon M Hirschfield, Chaya Shwaartz, Trevor W Reichman, Blayne Amir Sayed, Markus Selzner, Mamatha Bhat, Cynthia Tsien, Elmar Jaeckel, Les Lilly, Ian D McGilvray, Mark Steven Cattral, Gonzalo Sapisochin, Gonzalo Sapisochin
Pursuing living donor liver transplantation improves outcomes of patients with autoimmune liver diseases: An intention-to-treat analysis. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2024)
Fernanda Onofrio, Katina Zheng, Cherry Xu, Shiyi Chen, Wei Xu, Mary Vyas, Katie Bingham, Keyur Patel, Leslie Lilly, Mark Cattral, Nazia Selzner, Elmar Jaeckel, Cynthia Tsien, Aliya Gulamhusein, Gideon M Hirschfield, Mamatha Bhat
Living donor liver transplantation can address disparities in transplant access for patients with primary sclerosing cholangitis. Hepatology communications 7 (8) (2023)
Christopher L Bowlus, Bertus Eksteen, Angela C Cheung, Douglas Thorburn, Cynthia A Moylan, Paul J Pockros, Lisa M Forman, Alejandro Dorenbaum, Gideon M Hirschfield, Ciara Kennedy, Thomas Jaecklin, Andrew McKibben, Elaine Chien, Marshall Baek, Pamela Vig, Cynthia Levy
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatology communications 7 (6) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Christopher L Bowlus, Bertus Eksteen, Angela C Cheung, Douglas Thorburn, Cynthia A Moylan, Paul J Pockros, Lisa M Forman, Alejandro Dorenbaum, Gideon M Hirschfield, Ciara Kennedy, Thomas Jaecklin, Andrew McKibben, Elaine Chien, Marshall Baek, Pamela Vig, Cynthia Levy
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatology communications 7 (6) (2023)
Victoria L Mulcahy, Evaggelia Liaskou, Jose-Ezequiel Martin, Prasanti Kotagiri, Jonathan Badrock, Rebecca L Jones, Simon M Rushbrook, Stephen D Ryder, Douglas Thorburn, Simon D Taylor-Robinson, Graeme Clark, Heather J Cordell, Richard N Sandford, David E J Jones, Gideon M Hirschfield, George F Mells
Regulation of immune responses in primary biliary cholangitis: a transcriptomic analysis of peripheral immune cells. Hepatology communications 7 (4) (2023)
Christopher L Bowlus, Bertus Eksteen, Angela C Cheung, Douglas Thorburn, Cynthia A Moylan, Paul J Pockros, Lisa M Forman, Alejandro Dorenbaum, Gideon M Hirschfield, Ciara Kennedy, Thomas Jaecklin, Andrew McKibben, Elaine Chien, Marshall Baek, Pamela Vig, Cynthia Levy
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatology communications 7 (6) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Christopher L Bowlus, Bertus Eksteen, Angela C Cheung, Douglas Thorburn, Cynthia A Moylan, Paul J Pockros, Lisa M Forman, Alejandro Dorenbaum, Gideon M Hirschfield, Ciara Kennedy, Thomas Jaecklin, Andrew McKibben, Elaine Chien, Marshall Baek, Pamela Vig, Cynthia Levy
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatology communications 7 (6) (2023)
Laura Martinez-Gili, Alexandros Pechlivanis, Julie Anne Kathryn McDonald, Sofina Begum, Jonathan Badrock, Jessica Katharine Dyson, Rebecca Jones, Gideon M Hirschfield, Stephen D Ryder, Richard Sandford, Simon Rushbrook, Douglas Thorburn, Simon D Taylor-Robinson, Mary M E Crossey, Julian R Marchesi, George Mells, Elaine Holmes, David Jones
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis. Gut microbes 15 (1) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Laura Martinez-Gili, Alexandros Pechlivanis, Julie Anne Kathryn McDonald, Sofina Begum, Jonathan Badrock, Jessica Katharine Dyson, Rebecca Jones, Gideon M Hirschfield, Stephen D Ryder, Richard Sandford, Simon Rushbrook, Douglas Thorburn, Simon D Taylor-Robinson, Mary M E Crossey, Julian R Marchesi, George Mells, Elaine Holmes, David Jones
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis. Gut microbes 15 (1) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces interleukin-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Laura Martinez-Gili, Alexandros Pechlivanis, Julie Anne Kathryn McDonald, Sofina Begum, Jonathan Badrock, Jessica Katharine Dyson, Rebecca Jones, Gideon M Hirschfield, Stephen D Ryder, Richard Sandford, Simon Rushbrook, Douglas Thorburn, Simon D Taylor-Robinson, Mary M E Crossey, Julian R Marchesi, George Mells, Elaine Holmes, David Jones
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis. Gut microbes 15 (1) (2023)
Gideon M Hirschfield, Mitchell L Shiffman, Gideon M Hirschfield, Kris V Kowdley, John M Vierling, Cynthia Levy, Andreas E Kremer, Ehud Zigmond, Pietro Andreone, Stuart C Gordon, Christopher L Bowlus, Eric J Lawitz, Richard J Aspinall, Daniel S Pratt, Karina Raikhelson, Maria S Gonzalez-Huezo, Michael A Heneghan, Sook-Hyang Jeong, Alma L Ladrón de Guevara, Marlyn J Mayo, Georgios N Dalekos, Joost Paulus Hubertus Drenth, Ewa Janczewska, Barbara A Leggett, Frederik Nevens, Víctor Vargas, Eli Zuckerman, Christophe Corpechot, Eduardo Fassio, Holger Hinrichsen, Invernizzi Pietro, Palak J Trivedi, Lisa Forman, David E J Jones, Stephen D Ryder, Mark G Swain, Alexandra Steinberg, Pol F Boudes, Yun-Jung Choi, Charles A McWherter, null null
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. Hepatology (Baltimore, Md.) (2023)
Christopher L Bowlus, Bertus Eksteen, Angela C Cheung, Douglas Thorburn, Cynthia A Moylan, Paul J Pockros, Lisa M Forman, Alejandro Dorenbaum, Gideon M Hirschfield, Ciara Kennedy, Thomas Jaecklin, Andrew McKibben, Elaine Chien, Marshall Baek, Pamela Vig, Cynthia Levy
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatology communications 7 (6) (2023)
Marlyn J Mayo, John M Vierling, Christopher L Bowlus, Cynthia Levy, Gideon M Hirschfield, Guy W Neff, Michael R Galambos, Stuart C Gordon, Brian B Borg, Stephen A Harrison, Paul J Thuluvath, Aparna Goel, Mitchell L Shiffman, Mark G Swain, David E J Jones, Palak J Trivedi, Andreas E Kremer, Richard J Aspinall, David A Sheridan, Yvonne Dörffel, Ke Yang, Yun-Jung Choi, Charles A McWherter
Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis. Alimentary pharmacology & therapeutics (2023)
Adriaan J van der Meer, Maren H Harms, Christophe Corpechot, Douglas Thorburn, Invernizzi Pietro, Harry L A Janssen, Pier M Battezzati, Frederik Nevens, Keith D Lindor, Annarosa Floreani, Cyriel Y Ponsioen, Marlyn J Mayo, Albert Parés, Andrew L Mason, Kris V Kowdley, Palak J Trivedi, Gideon M Hirschfield, Karen Schmidt, George N Dalekos, Nikolaos K Gatselis, Xavier P D M J Verhelst, Willem J Lammers, Bettina E Hansen, Henk R van Buuren, Adriaan J van der Meer, null null
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid. Alimentary pharmacology & therapeutics 56 (9) (2022)
Debashis Haldar, Ashnila Janmohamed, Tim Plant, Matthew Davidson, Hannah Norman, Emily Russell, Olivia Serevina, Kenneth Chung, Kashif Qamar, Bridget Gunson, Bettina Hansen, Alex Richter, Palak J Trivedi, Gideon M Hirschfield
Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis. Liver international : official journal of the International Association for the Study of the Liver 41 (3) (2021)
Palak J Trivedi, Gideon M Hirschfield
Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut 70 (10) (2021)
Surain B Roberts, Bettina E Hansen, Saeha Shin, Lusine Abrahamyan, Lauren Lapointe-Shaw, Harry L A Janssen, Fahad Razak, Amol A Verma, Gideon M Hirschfield
Internal medicine hospitalisations and liver disease: a comparative disease burden analysis of a multicentre cohort. Alimentary pharmacology & therapeutics 54 (5) (2021)
Surain B Roberts, Amol A Verma, Gideon M Hirschfield
Editorial: liver disease in secondary care-'money or your life'. Authors' reply. Alimentary pharmacology & therapeutics 54 (6) (2021)
Kristel K Leung, Audrey Kim, Bettina E Hansen, Les Lilly, Gonzalo Sapisochin, Keyur Patel, Mamatha Bhat, Gideon M Hirschfield, Zita Galvin
The Impact of Primary Liver Disease and Social Determinants in a Mixed Donor Liver Transplant Program: A Single-Center Analysis. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 27 (12) (2021)
Kristel K Leung, Maya Deeb, Gideon M Hirschfield
Review article: pathophysiology and management of primary biliary cholangitis. Alimentary pharmacology & therapeutics 52 (7) (2020)
Palak J Trivedi, J Reece, Richard W Laing, E Slaney, Rachel Cooney, B K Gunson, Sivesh Kathir Kamarajah, Thomas D Pinkney, F Thompson, Paolo Muiesan, A Schlegel, Gideon M Hirschfield, Tariq H Iqbal, James W Ferguson
The impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis. Alimentary pharmacology & therapeutics 48 (3) (2018)
Peter J Eddowes, N McDonald, N Davies, S I K Semple, T J Kendall, J Hodson, Philip Noel Newsome, R B Flintham, R Wesolowski, L Blake, R V Duarte, C J Kelly, A H Herlihy, M D Kelly, S P Olliff, S G Hübscher, Jonathan Andrew Fallowfield, Gideon M Hirschfield
Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics 47 (5) (2017)